P L Amlot

Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients

Björn Nashan, Richard H. Moore, P L Amlot et al. · The Lancet · 1997 · 762 citations

Life Sciences, Immunology, Nephrology +15

Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial

Tanzina Haque, Gwen Wilkie, Marie M. Jones et al. · Blood · 2007 · 644 citations

Life Sciences, Hematology, Immunology +15

Incubation Phase of Acute Hepatitis B in Man: Dynamic of Cellular Immune Mechanisms

George Webster, Stephanie Reignat, Mala K. Maini et al. · Hepatology · 2000 · 416 citations · Full text

Life Sciences, Immunology, Pathology +17

Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells

Tanzina Haque, Gwen Wilkie, Clare Taylor et al. · The Lancet · 2002 · 365 citations

Life Sciences, Hematology, Immunology +14

Up-regulation of endoglin on vascular endothelial cells in human solid tumors: implications for diagnosis and therapy.

Francis Burrows, Elaine J. Derbyshire, Pier Luigi Tazzari et al. · PubMed · 1995 · 336 citations

Medicine, Cell Biology, Oncology +10